• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊髓血管母细胞瘤的神经学转归:一项关于35例手术病例的国际观察性多中心研究

Neurological Outcome of Spinal Hemangioblastomas: An International Observational Multicenter Study About 35 Surgical Cases.

作者信息

Alsereihi Motaz, Creatura Donato, D'Onofrio Ginevra F, Vandenbulcke Alberto, Messerer Mahmoud, Penet Nicolas, Lozano-Madrigal Raul, Delaidelli Alberto, Pessina Federico, Capo Gabriele, Barrey Cédric Y

机构信息

Department of Spine and Spinal Cord Surgery, Hôpital Pierre Wertheimer, GHE, Hospices Civils de Lyon, Claude Bernard University of Lyon 1, 59 Boulevard Pinel, 69677 Lyon, France.

Department of Surgery, Umm Al-Qura University, Mecca 24382, Saudi Arabia.

出版信息

Cancers (Basel). 2025 Apr 24;17(9):1428. doi: 10.3390/cancers17091428.

DOI:10.3390/cancers17091428
PMID:40361357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12070844/
Abstract

INTRODUCTION

Hemangioblastomas (HBs) are benign, highly vascular tumors that can be found intracranially or in the spinal region, representing around 2-15% of primary intramedullary tumors. They can occur sporadically or in association with Von Hipple-Lindau (VHL) disease. Despite recent of advancement of nonsurgical treatments, complete surgical resection remains the gold standard of care for the spinal HBs.

MATERIALS AND METHODS

We conducted an international multicenter retrospective analysis of adult patients surgically treated for spinal HBs in four European referral centers between January 2000 and September 2024, with a minimum post-operative follow-up duration of 6 months. Patients' sex and age at surgical intervention, clinical presentation, and duration symptoms prior to clinical diagnosis were identified. The pre- and post-operative neurological status at 1 and 6 months and at the last visit was assessed using the modified McCormick score (MCS). The extent of surgical resection was divided into gross total resection (GTR) and subtotal resection (STR). Finally, post-operative complications were inspected as well, namely cerebrospinal fluid leaks, infections, hemorrhages and post-operative spinal stability.

RESULTS

A total of 35 patients were included in the cohort, with an age median of 52 years (34.5-60) and a slight male predominance (21/35, i.e., 60%). The median follow-up period was 37.5 months (12-75). More than half were located in the cervical region, making it the most common (54.3%). Syrinxes were observed in 23 cases (72%), and HBs were more commonly intramedullary (80%). GTR was achievable in around 88% of cases. Post-operative complications were observed in nine patients (25.7%). Nearly half of patients were discharged into rehabilitations centers (48.5%). Tumor recurrence was seen in 10.3% only. At the last follow-up, an excellent overall post-operative neurological status (positive ∆ McCormick) was observed in most of patients (88%) and was found to be associated with a relatively younger age group. Tumor location and presence of syrinxes did not show any statistical significance regarding clinical outcome. In patients having benefited from intra-operative monitoring, only D-wave changes showed statistical significance regarding post-operative outcome ( < 0.05).

CONCLUSIONS

A large majority of patients operated for a spinal HB demonstrated favorable outcome after surgery, with unchanged or improved neurological status. Advanced age could have an impact on the post-operative neurological outcome. Other factors such as tumor size, location, and the presence of syrinx did not seem to significantly impact the neurological outcome. Finally, the surgery of these vascular lesions with no possibility of debulking or piece-meal removal and requiring "en bloc" resection is technically demanding and should be performed by experienced teams in spine and spinal cord surgery only.

摘要

引言

血管母细胞瘤(HBs)是一种良性、高血管性肿瘤,可发生于颅内或脊髓区域,约占原发性髓内肿瘤的2%-15%。它们可散发出现,也可与冯·希佩尔-林道(VHL)病相关。尽管近期非手术治疗有所进展,但完全手术切除仍是脊髓HBs治疗的金标准。

材料与方法

我们对2000年1月至2024年9月期间在四个欧洲转诊中心接受脊髓HBs手术治疗的成年患者进行了一项国际多中心回顾性分析,术后最短随访时间为6个月。确定了患者手术干预时的性别和年龄、临床表现以及临床诊断前的症状持续时间。使用改良麦考密克评分(MCS)评估患者在术后1个月、6个月及最后一次随访时的术前和术后神经状态。手术切除范围分为全切除(GTR)和次全切除(STR)。最后,还检查了术后并发症,即脑脊液漏、感染、出血和术后脊柱稳定性。

结果

该队列共纳入35例患者,年龄中位数为52岁(34.5-60岁),男性略占优势(21/35,即60%)。中位随访期为37.5个月(12-75个月)。超过一半位于颈椎区域,使其成为最常见的部位(54.3%)。23例(72%)观察到脊髓空洞症,HBs更常见于髓内(80%)。约88%的病例可实现GTR。9例患者(25.7%)观察到术后并发症。近一半患者出院后进入康复中心(48.5%)。仅10.3%出现肿瘤复发。在最后一次随访时,大多数患者(88%)术后神经状态总体良好(麦考密克评分呈正向变化),且发现与相对年轻的年龄组相关。肿瘤位置和脊髓空洞症的存在在临床结果方面未显示出任何统计学意义。在接受术中监测的患者中,仅D波变化在术后结果方面显示出统计学意义(<0.05)。

结论

大多数接受脊髓HB手术的患者术后显示出良好的结果,神经状态未改变或有所改善。高龄可能对术后神经结果有影响。其他因素,如肿瘤大小、位置和脊髓空洞症的存在,似乎对神经结果没有显著影响。最后,这些血管性病变的手术无法进行减瘤或分块切除,需要“整块”切除,技术要求高,应由经验丰富的脊柱和脊髓手术团队进行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d4/12070844/f7a3b12f11ee/cancers-17-01428-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d4/12070844/d1cea69b2028/cancers-17-01428-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d4/12070844/f7a3b12f11ee/cancers-17-01428-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d4/12070844/d1cea69b2028/cancers-17-01428-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95d4/12070844/f7a3b12f11ee/cancers-17-01428-g002.jpg

相似文献

1
Neurological Outcome of Spinal Hemangioblastomas: An International Observational Multicenter Study About 35 Surgical Cases.脊髓血管母细胞瘤的神经学转归:一项关于35例手术病例的国际观察性多中心研究
Cancers (Basel). 2025 Apr 24;17(9):1428. doi: 10.3390/cancers17091428.
2
Spinal cord hemangioblastomas: significance of intraoperative neurophysiological monitoring for resection and long-term outcome.脊髓血管母细胞瘤:术中神经生理监测对切除及长期预后的意义
J Neurosurg Spine. 2017 Apr;26(4):483-493. doi: 10.3171/2016.8.SPINE16595. Epub 2016 Dec 16.
3
Minimally invasive resection of spinal hemangioblastoma: feasibility and clinical results in a series of 18 patients.脊柱血管母细胞瘤的微创切除:18例患者的可行性及临床结果
J Neurosurg Spine. 2019 Aug 9;31(6):880-889. doi: 10.3171/2019.5.SPINE1975. Print 2019 Dec 1.
4
En Bloc Resection for Spinal Cord Hemangioblastomas: Surgical Technique and Clinical Outcomes.整块切除术治疗脊髓血管母细胞瘤:手术技术与临床疗效。
J Neurol Surg A Cent Eur Neurosurg. 2024 Nov;85(6):577-584. doi: 10.1055/s-0043-1776707. Epub 2023 Nov 22.
5
Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease.冯·希佩尔-林道病患者脊髓血管母细胞瘤的外科治疗
J Neurosurg. 2003 Jan;98(1):106-16. doi: 10.3171/jns.2003.98.1.0106.
6
Surgical outcome of spinal cord hemangioblastomas.脊髓血管母细胞瘤的手术结果。
J Korean Neurosurg Soc. 2012 Sep;52(3):221-7. doi: 10.3340/jkns.2012.52.3.221. Epub 2012 Sep 30.
7
Hemangioblastomas and Other Vascular Origating Tumors of Brain or Spinal Cord.脑或脊髓的血管母细胞瘤和其他血管起源性肿瘤。
Adv Exp Med Biol. 2023;1405:377-403. doi: 10.1007/978-3-031-23705-8_14.
8
Early microsurgical treatment for spinal hemangioblastomas improves outcome in patients with von Hippel-Lindau disease.早期显微手术治疗脊髓血管母细胞瘤可改善von Hippel-Lindau病患者的预后。
Surg Neurol Int. 2012;3:6. doi: 10.4103/2152-7806.92170. Epub 2012 Jan 21.
9
Intramedullary hemangioblastomas: surgical results in 16 patients.髓内血管母细胞瘤:16例患者的手术结果
Neurosurg Focus. 2015 Aug;39(2):E18. doi: 10.3171/2015.5.FOCUS15171.
10
Long-term outcome and prognostic factors of intramedullary spinal hemangioblastomas.脊髓内血管母细胞瘤的长期预后及预后因素
Neurosurg Rev. 2020 Feb;43(1):169-175. doi: 10.1007/s10143-018-1025-2. Epub 2018 Aug 31.

本文引用的文献

1
Innovative solutions? Belzutifan therapy for hemangioblastomas in Von Hippel-Lindau disease: A systematic review and single-arm meta-analysis.创新解决方案?贝伐单抗治疗 von Hippel-Lindau 病中的血管母细胞瘤:系统评价和单臂荟萃分析。
J Clin Neurosci. 2024 Oct;128:110774. doi: 10.1016/j.jocn.2024.110774. Epub 2024 Aug 10.
2
Prognostic Factors of Spinal Intramedullary Hemangioblastoma : Analysis of Surgical Outcomes and Tumor Characteristics.脊髓髓内血管母细胞瘤的预后因素:手术结果与肿瘤特征分析
J Korean Neurosurg Soc. 2024 Nov;67(6):637-645. doi: 10.3340/jkns.2023.0221. Epub 2024 Apr 23.
3
Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience.
贝伐珠单抗治疗与 VHL 相关的中枢神经系统血管母细胞瘤成人患者:单中心经验。
J Neurooncol. 2023 Aug;164(1):239-247. doi: 10.1007/s11060-023-04395-3. Epub 2023 Jul 14.
4
Preoperative angiographic considerations and neurological outcome after surgical treatment of intradural spinal hemangioblastoma: a multicenter retrospective case series.硬脊膜内脊髓血管母细胞瘤手术治疗的术前血管造影考虑因素和神经预后:一项多中心回顾性病例系列研究。
J Neurooncol. 2023 Jan;161(1):107-115. doi: 10.1007/s11060-022-04213-2. Epub 2022 Dec 25.
5
Radiologic Characteristics of Spinal Hemangioblastomas in von Hippel Lindau Disease as Guidance in Clinical Interventions.von Hippel Lindau 病脊柱血管母细胞瘤的放射学特征及其在临床干预中的指导意义。
World Neurosurg. 2022 Dec;168:e67-e75. doi: 10.1016/j.wneu.2022.09.011. Epub 2022 Sep 17.
6
Chronological Progression and Management of Syringobulbia Caused by Spinal Hemangioblastoma: A Case Series and Review of the Literature.脊髓血管母细胞瘤所致延髓空洞症的时间进展和治疗:病例系列及文献复习。
World Neurosurg. 2022 Nov;167:e127-e136. doi: 10.1016/j.wneu.2022.07.118. Epub 2022 Aug 6.
7
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.FDA 批准概要:贝伐珠单抗用于 von Hippel-Lindau 病相关肿瘤。
Clin Cancer Res. 2022 Nov 14;28(22):4843-4848. doi: 10.1158/1078-0432.CCR-22-1054.
8
Stereotactic radiotherapy for spinal hemangioblastoma - disease control and volume analysis in long-term follow up.脊柱血管母细胞瘤的立体定向放射治疗——长期随访中的疾病控制与体积分析
Rep Pract Oncol Radiother. 2022 Mar 22;27(1):134-141. doi: 10.5603/RPOR.a2022.0003. eCollection 2022.
9
Spinal hemangioblastomas: analysis of surgical outcome and prognostic factors.脊髓血管母细胞瘤:手术结果和预后因素分析。
Neurosurg Rev. 2022 Apr;45(2):1645-1661. doi: 10.1007/s10143-021-01696-x. Epub 2021 Nov 25.
10
Novel Clinical Insights into Spinal Hemangioblastoma in Adults: A Systematic Review.成人脊髓血管母细胞瘤的新临床见解:系统评价。
World Neurosurg. 2022 Feb;158:1-10. doi: 10.1016/j.wneu.2021.10.105. Epub 2021 Oct 21.